ArticleEuropean journal of hybrid imaging2018
Article in European journal of hybrid imaging, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.
- Pooled it
- [Molecular imaging and biology · 2025Trial
- Comparative Evaluation of (World journal of nuclear medicine · 2025Article
- PSMA PET/CT imaging and its application to prostate cancer treatment.Japanese journal of radiology · 2025Review
- Comparative dosimetric evaluation of 68Ga-PSMA and 18F-Choline PET/CT imaging in prostate cancer: implications for radiation safety and SUVmax correlation.Frontiers in nuclear medicine · 2025Article
- Head-to-Head Comparison of [Current oncology (Toronto, Ont.) · 2023Article
- Management of late events after conventional radical prostate radiotherapy: against the odds of secondary tumours and recurrence of prostate cancer.BMJ case reports · 2021Article
- Diagnostic Performance of [Journal of clinical medicine · 2020Article
- [Prostate-specific membrane antigen (PSMA)-based diagnostics and treatment of prostate cancer].Der Urologe. Ausg. A · 2019Review
- Carbon 11-choline positron emission tomography/computed tomography and palliative local therapy for castration-resistant prostate cancer.International urology and nephrology · 2019Article
- Radiolabelled choline versus PSMA PET/CT in prostate cancer restaging: a meta-analysis.American journal of nuclear medicine and molecular imaging · 2019Article
- Regularized reconstruction of digital time-of-flightTheranostics · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe aim of this study was to prospectively compare the detection rate of
methodsWe analysed 36 patients who underwent both
resultsBoth scans were positive in 18 patients (50%) and negative in 8 patients (22%). Nine patients were positive with
conclusionsIn patients with prostate cancer with biochemical recurrence
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.